Percheron Therapeutics Ltd (per) Logo

Percheron Therapeutics Ltd (PER)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

PER ASX Chart

Snapshot

Percheron Therapeutics Limited (PER, formerly Antisense Therapeutics Limited), is a publicly listed biotechnology company developing and commercializing pharmaceuticals for rare diseases with unmet medical need. The company involves in development of ATL1102, an antisense inhibitor of the CD49d receptor, which is currently the subject of an ongoing international Phase IIb trial for non-ambulant subjects with Duchenne Muscular Dystrophy.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +21.62%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 980 of 2,360
Sector Rank 82 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies NTI / PEB / PAR
EPS -$0.014
DPS $0.00
Book Value Per Share $0.01

Broker Consensus

PER is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website www.percherontx.com
Registry BoardRoom
Auditor Ernst and Young
Date Listed 20 Dec 2001

Upcoming Calendar (Forecasted)

Date Event
21/11/2024 AGM
26/02/2025 Report (Interim)
28/08/2025 Report (Prelim)
28/08/2025 Report (Annual)

Former Company Names

  • Antisense Therapeutics Limited (ANP), 03/01/2024

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

PER directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
29/11/23 James Garner Issued 6,690,000 $0.06 $401,400 Issue of options
26/09/23 Ben Price Buy +400,000 $0.071 $28,400 On-market trade

Director Interests

The current holdings of PER directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Charmaine Gittleson 30/06/2024 N/A 733,333 3,006,667 N/A
James Garner 30/06/2024 1,000,000 N/A 6,690,000 N/A
Ben Price 30/06/2024 999,805 N/A 1,000,000 N/A
Robert Moses 15/12/2021 9,090,201 0 10,000,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 20, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 101,082,863 11.21%
Citicorp Nominees Pty Limited 31,193,098 3.46%
Mutual Investments Pty Ltd <Mitchell Family A/C> 29,848,103 3.31%
BNP Paribas Nominees Pty Ltd <Clearstream> 19,776,361 2.19%
Jamplat Pty Ltd 15,000,000 1.66%
Mr Dale Anthony Reed 13,050,000 1.45%
Esarad Holdings Pty Ltd 12,300,888 1.36%
Citycastle Pty Ltd 11,688,075 1.30%
National Nominees Limited 9,430,584 1.05%
Mr Robert William Moses 9,300,000 1.03%
Mr Robertson Mclennan Mitchell & Mrs Karen Joy Mitchell 8,455,319 0.94%
Shared Office Services Pty Ltd <Philanne S/F A/C> 6,946,304 0.77%
Mr Jesse Gareth Hedley & Mrs Katie Louise Hedley <Ttm Family A/C> 6,690,000 0.74%
Mutual Investments Pty Ltd <The Mitchell Super Fund A/C> 6,600,000 0.73%
Mr Glen Stephen Hanly 6,265,005 0.69%
Xcelerate Trading Pty Ltd <Xcelerate Trading A/C> 6,060,000 0.67%
Mrs Margaret Ann Ryan & Mr Micheal Rodney Ryan 5,550,000 0.62%
Kyriaco Barber Pty Ltd 5,000,000 0.56%
Mr Mark Diamond 4,893,722 0.54%
Statemoor Pty Ltd <Peters Sf A/C> 4,830,769 0.54%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 73 111 379 1,871 1,026 3,460

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Platinum Investment Management Limited 20/08/2024 96,266,694 10.70

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
24-04-24 Platinum Investment Management Limited 14,488,464 12.3 10.68
16-10-23 Platinum Investment Management Limited 727,982 13.3 12.29

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.085 28 June
2023 $0.059 30 June
2022 $0.075 30 June
2021 $0.195 30 June
2020 $0.074 30 June
2019 $0.045 28 June
2018 $0.025 29 June
2017 $0.033 30 June
2016 $0.031 30 June
2015 $0.115 30 June
2014 $0.14 30 June
PER Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.